Company / Current Liabilities per Share
Emergent BioSolutions Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.54
FY2025
5-year range
$2.54 / $23.96
FY2021-FY2025
Trend
-15.2%
vs FY2024
Sector context
#60 of 210
Health Care
What the data says
At $2.54, Emergent BioSolutions Inc.'s current liabilities per share ranks #151 of 210 in the Health Care sector. Current Liabilities per Share has declined for 3 consecutive years, from $23.96 in FY2022 to $2.54 in FY2025.
Based on SEC 10-K filings.
2.54 in FY2025 with a 5-year CAGR of -19.4%.
Improved from $12.48 to $2.54 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -52.7%
- 5-Year CAGR
- -19.4%
- 10-Year CAGR
- -
Sector benchmark
#151 of 210 in Health CareTop 71% of 210This company $2.54 Sector average $23.79
▼
-89.3% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 15.2% year-over-year.
- Ranks #60 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.54 | -15.2% |
| FY2024 | $2.99 | -76.0% |
| FY2023 | $12.48 | -47.9% |
| FY2022 | $23.96 | +228.8% |
| FY2021 | $7.29 | -2.0% |
| FY2020 | $7.44 | +77.8% |
| FY2019 | $4.18 | +3.1% |
| FY2018 | $4.06 | +64.4% |
| FY2017 | $2.47 | -8.2% |
| FY2016 | $2.69 | +1.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026